Organs-on-chips Harvard spinout

    Emulate, a Cambridge, Massachusetts–based developer of 'organ-on-a-chip' systems, completed a $12-million series A round led by venture capital firm NanoDimension, Cedars-Sinai Medical Center and philanthropist Hansjorg Wyss, at whose eponymous Harvard incubator the startup was formed. The technology, a computer chip surrounded by living cells that mimic human physiology, could be ready for commercialization as soon as 2016, according to Emulate CEO James Coon.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Organs-on-chips Harvard spinout. Nat Biotechnol 32, 849 (2014). https://doi.org/10.1038/nbt0914-849b

    Download citation